Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development

Journal of Virology

Volumn 77, Issue 1, 2003, Pages 105-114

  Portis, Toni ^a   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA BINDING; DNA MICROARRAY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; IMMUNE DEFICIENCY; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VIRUS LATENCY;

ANIMALS; B-LYMPHOCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DNA; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION FACTORS; VIRAL MATRIX PROTEINS;

EID: 0037213918     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.1.105-114.2003     Document Type: Article

References (75)

1. Adjei, A. A. 2001. Blocking oncogenic Ras signaling for cancer therapy. J. Natl. Cancer Inst. 93:1062-1074.
2. Akao, I., Y. Sato, K. Mukai, H. Uhara, S. Furuya, T. Hoshikawa, Y. Shimosato, and I. Takeyama. 1991. Detection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in situ hybridization. Laryngoscope 101:279-283.
3. Alexander, F. E., C. P. Daniel, A. A. Armstrong, D. A. Clark, D. E. Onions, R.A. Cartwright, and R. F. Jarrett. 1995. Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin's disease: Results of a case-control study. Eur. J. Cancer 9:1479-1486.
4. Ambinder, R. F. 2001. Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur. J. Cancer 37:1209-1216.
5. Babcock, G. J., L. L. Decker, M. Volk, and D. A. Thorley-Lawson. 1998. EBV persistence in memory B cells in vivo. Immunity 9:395-404.
6. Bain, G., C. B. Cravatt, C. Loomans, J. Alberolaa, S. M. Hedrick, and C. Murre. 2001. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat. Immunol. 2:165-171.
7. Bain, G., E. C. Maandag, D. J. Izon, D. Amsen, A. M. Kruisbeek, B. C. Weintraub, I. Krop, M. S. Schlissel, A. J. Feeney, and M. van Roon. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885-892.
8. Bartel, F. O., T. Higuchi, and D. D. Spyropoulos. 2000. Mouse models in the study of the Ets family of transcription factors. Oncogene 19:6443-6454.
9. Becker-Herman, S., F. Lantner, and I. Shachar. 2002. Id2 negatively regulates B cell differentiation in the spleen. J. Immunol. 168:5507-5513.
10. Begley, C. G., and A. R. Green. 1999. The SCL gene: From case report to critical hematopoietic regulator. Blood 93:2760-2770.
11. Burkhardt, A. L., J. B. Bolen, E. Kieff, and R. Longnecker. 1992. An Epstein-Barr virus transformation-associated membrane protein interacts with Src family tyrosine kinases J. Virol. 66:5161-5167.
12. Caldwell, R. G., R. C. Brown, and R. Longnecker. 2000. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EμLMP2A transgenic mice. J. Virol. 74:1101-1113.
13. Caldwell, R. G., J. B. Wilson, S. J. Anderson, and R. Longnecker. 1998. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9:405-411.
14. Campbell, M. A., and B. M. Sefton. 1992. Association between B-lymphocyte membrane immunoglobulin and multiple members of the Src family of protein tyrosine kinases. Mol. Cell. Biol. 12:2315-2321.
15. Chan, J. K., W. Y. Tsang, C. S. Ng, C. S. Wong, and E. S. Lo. 1995. A study of the association of Epstein-Barr virus with Burkitt's lymphoma occurring in a Chinese population. Histopathology 26:239-245.
16. Chen, F., J. Z. Zou, and L. di Renzo. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:3752-3758.
17. Chen, S.-Y., J. Lu, Y.-C. Shih, and C.-H. Tsal. 2002. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J. Virol. 76:9556-9561.
18. Cohen, J. I. 2000. Epstein-Barr virus infection. N. Engl. J. Med. 343:481-492.
19. Cossman, J., C. M. Annunziata, S. Barash, L. Staudt, P. Dillon, W.-W. He, P. Ricciardi-Castagnoli, C. A. Rosen, and K. C. Carter. 1999. Reed-Sternberg cell genome expression supports a B-cell lineage. Blood 94:411-416.
20. DeFranco, A. L. 1997. The complexity of signaling pathways activated by the BCR. Curr. Opin. Immunol. 9:296-308.
21. Dykstra, M. L., R. Lengnecker, and S. K. Pierce. 2001. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity 14:57-67.
22. Engel, I., and C. Murre. 2001. The function of E- and Id proteins in lymphocyte development. Nat. Rev. Immunol. 1:193-199.
23. Engels, N., M. Merchant, R. Pappu, A. C. Chan, R. Longnecker, and J. Wienands, 2001. Epstein-Barr virus latent membrane protein 2a (LMP2A) employs the SLP-65 signaling module. J. Exp. Med. 194:255-264.
24. Era, T., M. Ogawa, S. Nishikawa, M. Okamoto, T. Honjo, K. Akagi, J. Miyazaki, and K. Yamamura. 1991. Differentiation of growth signal requirement of B lymphocyte precursor is directed by expression of immunoglobulin. EMBO J. 10:337-342.
25. Fruehling, S., and R. Longnecker. 1997. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235:241-251.
26. Fruehling, S., R. Swart, K. M. Dolwick, E. Kremmer, and R. Longnecker. 1998. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J. Virol. 72:7796-7806.
27. Glimcher, L. H., and H. Singh. 1999. Transcription factors in lymphocyte development - T and B cells get together. Cell 96:13-23.
28. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213-1225.
29. Henderson, A., and K. Calame. 1998. Transcriptional regulation during B cell development. Annu. Rev. Immunol. 16:163-200.
30. Herblot, S., P. D. Aplan, and T. Hoang. 2002. Gradient of E2A activity in B-cell development. Mol. Cell. Biol. 22:886-900.
31. Horcher, M., A. Souabn, and M. Busslinger. 2001. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14:779-790.
32. Hsu, H. L., I. Wadman, J. T. Tsan, and R. Baer. 1994. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc. Natl. Acad. Sci. USA 91:5947-59511.
33. Jundt, F., K. Kley, I. Anagnostopoulos, K. S. Probsting, A. Greiner, S. Mathas, C. Scheidereit, T. Wirth, H. Stein, and B. Dorken. 2002. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood 99: 3060-3062.
34. Jundt, F., I. Anagnostopoulos, R. Forster, S. Mathas, H. Stein, and B. Dorken. 2002. Activated Notch 1 signaling promotes Tumor cell proliferation and survival in Hodgkin's and anaplastic large cell lymphoma. Blood 99:3398-3403.
35. Kee B. L., and C. Murre. 1998. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J. Exp. Med. 188:699-713.
36. Kee, B. L., and C. Murre. 2001. Transcription factor regulation of B lineage commitment. Curr. Opin. Immunol. 13:180-185.
37. Khan, G., and P. J. Coates. 1994. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease. J. Pathol. 174:141-149.
38. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 1109-1162. In. B. N. Fields, D. M. Knípe, and P. M. Howley (ed.), Fields Virology, Lippincott-Raven Publishers, Philadelphia, Pa.
39. Kuppers, R., I. Sehwering, A. Brauninger, K. Rajewsky, and M.-L. Hansmann. 2002. Biology of Hodgkin's lymphoma. Ann. Oncol. 13:11-18.
40. Kurosaki, T. 1999. Genetic analysis of B cell antigen receptor signaling. Annu. Rev. Immunol. 17:555-592.
41. Kurth, J., T. Spieker, J. Wustrow, G. J. Strickler, L. M. Hansmann, K. Rajewsky, and R. Kuppers. 2000. EBV-infected B cells in infectious mononucleosis: Viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13:485-495.
42. Longneeker, R. 2000. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Adv. Cancer Res. 79:175-200.
43. Merchant, M., R. G. Caldwell, and R. Longnecker. 2000. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J. Virol. 74:9115-9124.
44. Merchant, M., and R. Longnecker. 2001. LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways. Virology 291:46-54.
45. Miller, C. L., A. L. Burkhardt, J. H. Lee, B. Stealey, R. Longnecker, J. B. Bolen, and E. Kieff. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166.
46. Miller, C. L., J. H. Lee, E. Kieff, and R. Longneeker. 1994. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad. Sci. USA 91:772-776.
47. Miller, C. L., R. Longnecker, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J. Virol. 67:3087-3094.
48. Miyashita, E. M., B. Yang, G. J. Babcock, and D. A. Thorley-Lawson. 1997. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J. Virol. 71:4882-4891.
49. Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777-783.
50. Nagaoka, H., Y. Takahashi, R. Hayashi, T. Nakamura, K. Ishii, J. Matsuda, A. Ogura, Y. Shirakata, H. Karasuyama, T. Sudo, S.-I. Nishikawa, T. Tsubata, T. Mizuochi, T. Asano, H. Sakano, and T. Takemori. 2000. Ras mediates effector pathways responsible for pre-B cell survival, which is essential for the developmental progression to the late pre-B cell stage. J. Exp. Med. 192:171-181.
51. Nutt, S. L., B. Heavey, A. G. Rolink, and M. Busslinger, 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:556-562.
52. Nutt S. L., P. Urbanek, A. Rolink, and M. Busslinger. 1997. Essential functions of Pax5 (BSAP) in pro-B cell development: Difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11:476-491.
53. Oikawa, T., T. Yamada, F. Kihara-Negishi, H. Yamamoto, N. Kondoh, Y. Hitomi, and Y. Hashimoto. 1999. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis. Cell Death Diff. 6:599-608.
54. Ordentlich, P., A. Lin, C. P. Shen, C. Blaumueller, K. Matsuno, S. Artavanis-Tsakonas, and T. Kadesch. 1998. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol. Cell. Biol. 18:2230-2239.
55. O'Riordan, M., and R. Grossched. 1999. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11:21-31.
56. Osborne, B., and L. Miele. 1999. Notch and the immune system. Immunity 11:653-663.
57. Panousis, C. G., and D. T. Rowe. 1997. Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for milogen-activated protein kinase. J. Virol. 71:4752-4760.
58. Qu, L., and D. Rowe. 1992. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66:3715-3724.
59. Quong, M. W., D. P. Harris, S. L. Swain, and C. Murre. 1999. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18:6307-6318.
60. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields Virology. Lippin-Coll-Raven Publishers, Philadelphia, Pa.
61. Rothenberg, E. V., J. C. Telfer, and M. K. Anderson. 1999. Transcriptional regulation of lymphocyte lineage commitment. BioEssays 21:726-742.
62. Schaniel, C., M. Gottar, E. Roosnek, F. Melchers, and A. G. Rolink. 2002. Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones. Blood 99:2760-2766.
63. Scholle, F., K. M. Bendt, and N. Raab-Traub. 2000. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 74:10681-10689.
64. Shaw, A. C., W. Swat, L. Davidson, and F. W. Alt. 1999. Induction of Ig light chain gene rearrangement in heavy chain-deficient B cells by activated Ras. Proc. Natl. Acad. Sci. USA 96:2239-2243.
65. Shaw, A. C., W. Swat, R. Ferrini, L. Davidson, and F. W. Alt. 1999. Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes. J. Exp. Med. 189:123-129.
66. Shen, C.-P., and T. Kadesch. 1995. B-cell-specific DNA binding by an E47 homodimer. Mol. Cell. Biol. 15:4518-4524.
67. Sigvardsson, M., M. O'Riordan, and R. Grosschedl. 1997. EBF and E47 collaborate to induce expression of the endogenous immunglobulin surrogate light chain genes. Immunity 7:25-36.
68. Sun, X.-H. 1994. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79:893-900.
69. Sun, X. H., N. G. Copeland, N. A. Jenkins, and D. Baltimore. 1991. Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol. Cell. Biol. 11:6185-6191.
70. Thorley-Lawson, D. A. 2001. Epstein-Barr virus: Exploiting the immune system. Nature Rev. Immunol. 1:75-82.
71. Tierney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection in the carrier state. J. Virol. 68:7374-7385.
72. van de Wetering, M., W. de Lau, and H. Clevers. 2002. WNT signaling and lymphocyte development. Cell 109:S13-S19.
73. van Noort, M., and H. Clevers. 2002. TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev. Biol. 244:1-8.
74. Young, L. S., and M. Rowe. 1992. Epstein-Barr virus, lymphomas and Hodgkin's disease. Semin. Cancer Biol. 3:273-284.
75. Zhuang, Y., P. Soriano, and H. Weintraub. 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875-884.